Covered recipient · General Payments record
BRIAN VU
General Payments · PY2024–2025
$267.36
- Reported across 11 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $246.85 | 10 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $71.76 | 3 |
| Merz Pharmaceuticals, LLC | $52.84 | 2 |
| Ipsen Biopharmaceuticals, Inc | $46.71 | 2 |
| Amneal Pharmaceuticals LLC | $27.05 | 1 |
| MDD US Operations, LLC | $25.99 | 1 |
| Otsuka America Pharmaceutical, Inc. | $22.50 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (10)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $28.57 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204662707 | CMS |
| ABBVIE INC. | $22.93 | 08/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204662712 | CMS |
| ABBVIE INC. | $20.26 | 12/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1204662716 | CMS |
| Amneal Pharmaceuticals LLC | $27.05 | 09/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1220552502 | CMS |
| Ipsen Biopharmaceuticals, Inc | $22.61 | 02/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208869340 | CMS |
| Ipsen Biopharmaceuticals, Inc | $24.10 | 08/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1208869344 | CMS |
| MDD US Operations, LLC | $25.99 | 04/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241861525 | CMS |
| Merz Pharmaceuticals, LLC | $23.77 | 09/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232557277 | CMS |
| Merz Pharmaceuticals, LLC | $29.07 | 11/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1232557279 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.50 | 03/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227531884 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2024, 2025
- Source files
- Dataset page · Bulk file · PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.